Skinpharmacy Advanced Acne Therapy Kit
NDC Package 69842-082-01
Package Information
Skinpharmacy Advanced Acne Therapy Kit (salicylic acid, benzoyl peroxide) kits is use morning and night. This formulation utilizes a kit delivery system. Marketed by Cvs Health, this product is identified by NDC 69842-082 and is authorized under FDA application part333D.
Identification & Billing
- RxCUI: 106309 - benzoyl peroxide 5 % Topical Lotion
- RxCUI: 106309 - benzoyl peroxide 50 MG/ML Topical Lotion
- RxCUI: 1874139 - {1 (22 ML) (benzoyl peroxide 25 MG/ML Topical Lotion) / 1 (12 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) } Pack
- RxCUI: 1874139 - benzyol peroxide 2.5 % Topical Lotion (22 ML) / benzyol peroxide 5 % Topical Lotion (12 ML) / salicylic acid 2 % Medicated Liqiud Soap (118 ML) Pack
- RxCUI: 200009 - benzoyl peroxide 2.5 % Topical Lotion
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69842 - Cvs Health
- 69842-082 - Skinpharmacy Advanced Acne Therapy Kit
- 69842-082-01 - 1 KIT in 1 CARTON * 22 mL in 1 TUBE * 12 mL in 1 TUBE * 118 mL in 1 TUBE
- 69842-082 - Skinpharmacy Advanced Acne Therapy Kit
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69842-082-01 identifies a specific commercial package of 1 kit in 1 carton * 22 ml in 1 tube * 12 ml in 1 tube * 118 ml in 1 tube of Skinpharmacy Advanced Acne Therapy Kit, a human over the counter drug labeled by Cvs Health. This kit is formulated for topical use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Health on October 01, 2014. The current certification is valid through December 31, 2026.
How is this Cvs Health product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69842008201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.